 |
Biosimilars and MS: A Pathway Takes Shape |
| |
Many drugs currently approved to treat MS are technologically sophisticated and biologically rather than chemically derived, which can be a barrier in bringing generic versions of the drug to market. In the wake of healthcare reform, new practices for approving biosimilars, the name for generic biologics, are being introduced. This Q&A looks at the history of biosimilars and explains the new regulations for their approval and what these changes mean for the future of biosimilars. |
| |
|
|
Vacationing With MS |
| |
Whether you are planning a trip to an exotic location or visiting distant relatives and friends, this Q&A section offers ways to manage MS and its symptoms while enjoying your time away. |
| |
|
| |
Getting the Most From Your Office Visits |
| |
Visits to a doctor are a regular occurrence for people with MS, but sometimes the visits are too quick, and a person can leave with important questions unanswered. |
| |
|
| |
Your Questions Answered |
| |
The editors of Making Strides offer their expert responses to questions from readers on oral MS therapies and a trial that investigated testosterone treatment in men with MS. |
| |
|
| |
Complementary & Alternative Medicines |
| |
An estimated 75% of people with MS have taken a CAM to treat the disease and its symptoms. The editors of Making Strides answer questions on some of the most common of these unconventional treatments. |
| |
|
| |
Your Questions Answered - NAbs |
| |
Read this section to learn more about the effects of neutralizing antibodies (NAbs), which are types of antibodies the immune system can develop against the β-interferon therapies used to treat MS. |
| |
|
|
Your Questions Answered |
| |
Readers have been steadily sending in their MS-related questions, and the editors of Making Strides have once again provided their expert responses. Read this section to learn more on the heterogeneity of MS, how to deal with stress, and cognitive problems. |
| |
|
|
Clinical Trials |
| |
Before a drug or device becomes available for people to use, it must undergo several stages of clinical trials. People with MS may be interested in participating in a clinical trial because of the potential benefits. But there are risks involved that must be considered as the decision of whether to participate is carefully weighed. This issue’s Q&A answers some common questions people may have when thinking about participating in a clinical trial. |
| |
|
|
Your Questions Answered |
| |
When the editors of Making Strides receive questions submitted by readers, they pay attention. This issue’s Q&A is devoted entirely to the editors’ responses to some of the frequently asked questions readers have submitted. |
| |
|
|
Men's Health |
| |
Since twice as many women as men are afflicted with MS, men's health issues can be overlooked in discussions of the disease. This section offers answers to questions men may have when examining how MS affects various facets of their lifestyle. |
| |
|
|
Women's Health |
| |
The majority of people with MS are women. How the disease affects different life events women face is certainly of concern to many. This issue’s Q & A attempts to answer some of the questions women and their partners may have regarding things like pregnancy and menopause. |
| |
|
|
Archives |
| |
|
| |
|
